Mechanism of Action of Latanoprost

Introduction

Latanoprost is a prostaglandin F2α (PGF2α) analog used as a first-line agent in the management of open-angle glaucoma and ocular hypertension. It effectively lowers intraocular pressure (IOP) by increasing aqueous humor outflow, thereby preventing optic nerve damage and vision loss.

Mechanism of Action (Step-wise)

1. Prodrug Activation
   Latanoprost is administered as an isopropyl ester prodrug and is hydrolyzed in the cornea to its active form (latanoprost acid).
2. Activation of FP Prostaglandin Receptors
   The active drug binds to FP receptors located in the ciliary muscle.
3. Remodeling of Extracellular Matrix
   Activation of FP receptors induces changes in matrix metalloproteinases (MMPs), leading to remodeling of the extracellular matrix.
4. Increased Uveoscleral Outflow
   Structural changes in the ciliary muscle enhance the uveoscleral pathway for aqueous humor drainage.
5. Reduction in Intraocular Pressure (IOP)
   Increased outflow of aqueous humor leads to a sustained decrease in intraocular pressure.
6. Minimal Effect on Aqueous Humor Production
   Latanoprost primarily affects outflow rather than reducing aqueous humor formation.

Pharmacokinetics

• Administration: Topical (eye drops)
• Absorption: Rapid corneal absorption
• Activation: Hydrolysis in cornea
• Peak effect: 8–12 hours
• Duration: ~24 hours
• Metabolism: Hepatic
• Excretion: Renal

Clinical Uses

• Primary open-angle glaucoma
• Ocular hypertension
• First-line therapy for lowering intraocular pressure

Adverse Effects

• Increased iris pigmentation (irreversible)
• Eyelash growth (hypertrichosis)
• Conjunctival hyperemia
• Eye irritation
• Rare systemic effects

Comparative Analysis

Latanoprost is preferred as first-line therapy due to its strong efficacy, once-daily dosing, and minimal systemic side effects compared to β-blockers like timolol and systemic agents like acetazolamide.

MCQs

1. Latanoprost is an analog of:
   a) Prostaglandin E2
   b) Prostaglandin F2α
   c) Leukotriene
   d) Thromboxane
   Answer: b) Prostaglandin F2α
2. Primary mechanism:
   a) Decreases aqueous production
   b) Increases aqueous outflow
   c) Blocks β receptors
   d) Inhibits carbonic anhydrase
   Answer: b) Increases aqueous outflow
3. Site of action:
   a) Retina
   b) Cornea
   c) Ciliary muscle
   d) Lens
   Answer: c) Ciliary muscle
4. Type of drug:
   a) β-blocker
   b) Diuretic
   c) Prostaglandin analog
   d) Antibiotic
   Answer: c) Prostaglandin analog
5. Main pathway increased:
   a) Trabecular
   b) Uveoscleral
   c) Renal
   d) Hepatic
   Answer: b) Uveoscleral
6. Frequency of dosing:
   a) Once daily
   b) Twice daily
   c) Thrice daily
   d) Weekly
   Answer: a) Once daily
7. Common side effect:
   a) Cataract
   b) Iris pigmentation
   c) Blindness
   d) Retinal detachment
   Answer: b) Iris pigmentation
8. Latanoprost is a:
   a) Active drug
   b) Prodrug
   c) Antibiotic
   d) Steroid
   Answer: b) Prodrug
9. Effect on aqueous humor production:
   a) Decreases significantly
   b) No effect
   c) Increases
   d) Blocks completely
   Answer: b) No effect
10. Preferred use:
    a) Cataract
    b) Glaucoma
    c) Retinopathy
    d) Macular degeneration
    Answer: b) Glaucoma

FAQs

1. What is the mechanism of action of latanoprost?
   It increases uveoscleral outflow of aqueous humor, reducing intraocular pressure.
2. Why is latanoprost used once daily?
   Because it has a long duration of action (~24 hours).
3. Does latanoprost reduce aqueous humor production?
   No, it mainly increases outflow.
4. Why does latanoprost change eye color?
   It increases melanin production in the iris.
5. Is latanoprost a first-line drug for glaucoma?
   Yes, due to its efficacy and safety profile.
6. What is its major advantage?
   Minimal systemic side effects.

References

• Goodman & Gilman’s The Pharmacological Basis of Therapeutics – Ocular Pharmacology
• Katzung: Basic and Clinical Pharmacology – Drugs Used in Glaucoma
• Tripathi: Essentials of Medical Pharmacology
• Harrison’s Principles of Internal Medicine – Eye Disorders

Download